| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REPLIGEN CORP | Director | Common Stock | 2,894 | $403,510 | $139.43 | 15 May 2025 | Direct |
| Codiak BioSciences, Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 145,000 | 24 Jan 2023 | Direct | ||
| Codiak BioSciences, Inc. | Chief Technology Officer | Restricted Stock Units | 8,400 | 16 Feb 2023 | Direct | ||
| REPLIGEN CORP | Director | Stock Option (Right to Buy) | 1,800 | 15 May 2025 | Direct | ||
| Codiak BioSciences, Inc. | Chief Technology Officer | Common Stock | 0 | 28 Mar 2023 | Direct |